EU
ALXN
Emory University’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-18,235
| Closed | -$2.39M | – | 45 |
|
|
2019
Q2 | $2.39M | Sell |
18,235
-194
| -1% | -$25.4K | 1.68% | 22 |
|
|
2019
Q1 | $2.49M | Sell |
18,429
-1,238
| -6% | -$167K | 1.75% | 15 |
|
|
2018
Q4 | $1.92M | Sell |
19,667
-3,348
| -15% | -$326K | 1.51% | 26 |
|
|
2018
Q3 | $3.2M | Buy |
23,015
+934
| +4% | +$130K | 2.09% | 7 |
|
|
2018
Q2 | $2.74M | Buy |
22,081
+288
| +1% | +$35.8K | 1.82% | 15 |
|
|
2018
Q1 | $2.43M | Buy |
21,793
+5,020
| +30% | +$560K | 1.73% | 24 |
|
|
2017
Q4 | $2.01M | Buy |
16,773
+4,490
| +37% | +$537K | 1.72% | 15 |
|
|
2017
Q3 | $1.72M | Sell |
12,283
-1,324
| -10% | -$186K | 1.36% | 29 |
|
|
2017
Q2 | $1.66M | Sell |
13,607
-3,146
| -19% | -$383K | 1.46% | 20 |
|
|
2017
Q1 | $2.03M | Sell |
16,753
-904
| -5% | -$110K | 1.92% | 17 |
|
|
2016
Q4 | $2.16M | Buy |
+17,657
| New | +$2.16M | 2.13% | 7 |
|
|
2015
Q3 | $1.27M | Sell |
8,101
-1,178
| -13% | -$184K | 3.53% | 15 |
|
|
2015
Q2 | $1.68M | Buy |
+9,279
| New | +$1.68M | 2.27% | 5 |
|